| SpectraBase Spectrum ID |
LtrfL7s9dzi |
| Name |
N2-(3-Trifluoromethylbenzyl)-5-methoxytryptamine |
| Classification |
Tryptamine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
348.144947728 u |
| Formula |
C19H19F3N2O |
| InChI |
InChI=1S/C19H19F3N2O/c1-25-16-5-6-18-17(10-16)14(12-24-18)7-8-23-11-13-3-2-4-15(9-13)19(20,21)22/h2-6,9-10,12,23-24H,7-8,11H2,1H3 |
| InChIKey |
HRUOMGNWBODFJG-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
348.369 g/mol |
| Nominal Mass |
348 u |
| Quality |
998 |
| Retention Index |
2600 |
| SMILES |
C=12C(NC=C2CCNCC=2C=C(C(F)(F)F)C=CC2)=CC=C(C1)OC |
| SPLASH |
splash10-03di-0900000000-7f7f0b21852d34ac82f9 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
2-(5-Methoxy-1H-indol-3-yl)-N-([3-(trifluoromethyl)phenyl]methyl)ethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_020068 |
